Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07330505

Transducer Levelling Errors in Everyday ICU Practice - A Multicentre Blinded Observational Study

Invasive pressure monitoring (arterial blood pressure via arterial catheter and central venous pressure via central venous catheter) is fundamental to clinical decision-making in intensive care. Treatment with vasopressors, fluids, and nursing interventions depends on accurate measurements. Because pressure transducers are hydrostatic, even small levelling errors can produce clinically relevant deviations (approximately 1 mmHg per 1.3 cm of vertical misplacement). Such errors may contribute to inappropriate therapy, for example under-recognition of hypotension, unnecessary vasopressor escalation, or missed venous congestion.

This prospective, multicenter, blinded observational study will quantify transducer levelling deviations during routine ICU care and evaluate whether clinically relevant deviations are associated with treatment decisions. Adult mechanically ventilated ICU patients with an arterial catheter, a central venous catheter, and ongoing vasopressor therapy will be included at hospitals in Västra Götalandsregionen, Sweden. Two blinded reference lines/sensors will be placed at predefined physiological zero levels for MAP and CVP and connected in parallel to the patient monitoring system. Continuous deviation (mmHg) between the clinical transducer position and the blinded reference level will be recorded for 8 hours while clinical staff remain unaware of the reference setup. MAP/CVP-related treatment decisions (e.g., vasopressor adjustments, fluid therapy, and nursing interventions) will be recorded with timestamps.

The study will provide real-world data on the magnitude and frequency of invasive pressure transducer misalignment in daily ICU practice and its potential relationship to patient management.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sahlgrenska University Hospital, Gothenburg, Sweden

Loading trial locations.

About this study

This is a prospective, multicenter, blinded observational study evaluating the accuracy of invasive pressure transducer levelling for arterial pressure (mean arterial pressure, MAP) and central venous pressure (CVP) during routine intensive care. Adult mechanically ventilated ICU patients with an indwelling arterial catheter and central venous catheter receiving vasopressor therapy are observed without any protocol-mandated changes to standard clinical care.

To quantify levelling deviations without influencing clinical behavior, a parallel reference measurement setup is connected to the existing monitoring system. Two fluid-filled reference lines are connected in parallel to the pressure dome used for invasive monitoring and secured to the chest wall at the fourth intercostal space at half of the anteroposterior thoracic diameter, one on each side of the chest. This configuration allows continuous estimation of vertical deviation (mmHg) between the clinical transducer position and a predefined physiological reference level. During lateral positioning, deviation is calculated using the midpoint between the two reference lines as the reference. Reference lines are covered with dressings to maintain blinding of clinical staff to the reference levels.

Physiological waveforms and calculated deviations are recorded continuously for an 8-hour monitoring period for each participant. In parallel, treatment actions plausibly influenced by interpretation of MAP or CVP (including vasopressor titration, fluid administration or removal, and nursing interventions related to positioning or transducer handling) are documented with timestamps to allow temporal association analyses. Relevant contextual variables are collected to support interpretation of deviations and clinical responses.

Data quality is ensured through predefined measurement procedures, continuous digital waveform acquisition, synchronization of reference and clinical signals, and post hoc review of signal integrity. Periods affected by technical artifacts or signal loss are flagged according to predefined criteria. Data segments that are missing, uninterpretable, or invalid due to technical failure are treated as missing and excluded from analyses, without imputation.

The study is designed to quantify the magnitude and frequency of invasive pressure transducer misalignment during routine ICU care and to explore whether clinically relevant deviations are associated with contemporaneous treatment decisions, with the aim of informing patient safety and quality improvement initiatives.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥18 years
  • ICU admission
  • Mechanically ventilated
  • Arterial catheter for MAP
  • Central venous catheter for CVP
  • Ongoing vasopressor therapy

Exclusion criteria

  • Severe hemodynamic or respiratory instability
  • Contraindications for lateral positioning
  • Expected survival <24 hours

Treatment and study plan

Primary outcomes

  1. Mean deviation in transducer position for MAP and CVP

    Time frame: During the 8-hour continuous monitoring period following initiation of blinded reference monitoring

    Continuous deviation (mmHg) between the clinical transducer position and the blinded reference zero point. Continuous (mmHg).

Secondary outcomes

  1. Frequency of clinically relevant deviations

    Time frame: During the same 8-hour continuous monitoring period following initiation of blinded reference monitoring

    Proportion of monitoring time (%) with deviation >2 mmHg (CVP) or >5 mmHg (MAP). Percentage of total monitoring time.

  2. Association between deviations and treatment decisions

    Time frame: During the 8-hour continuous monitoring period, with treatment decisions assessed within 5 minutes following detection of a deviation

    Relationship between deviation size and treatment decisions (vasopressor adjustments, fluid therapy, nursing interventions). Binary outcome (decision yes/no), regression analysis.

  3. Differences in deviation magnitude and frequency across hospitals and ICU specialties.

    Time frame: During the 8-hour continuous monitoring period following initiation of blinded reference monitoring

    Differences in deviation magnitude and frequency across hospitals and ICU specialties. Continuous (mmHg), categorical (% above threshold).

  4. Hemodynamic context of deviations

    Time frame: At baseline and during the subsequent 8-hour continuous monitoring period

    Association between deviation magnitude and concurrent patient status (SOFA, MAP, CVP, CO, SVR, temperature). Continuous and categorical variables.

Study contacts

Contact information is provided by the study sponsor or research team.

Carl Sjödin, PhD student

CONTACT

[email protected]

+46313421096

Lotta Johansson, PhD

CONTACT

[email protected]

0708199664

Sponsors and collaborators

Lead sponsor

Vastra Gotaland Region

Other Gov

Registry information

Important dates

Study start
2026
Primary completion
2027
Study completion
2027
First posted
Jan 9, 2026
Registry last updated
Jul 7, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.